Infliximab for very early‐onset inflammatory bowel disease: A tertiary center experience in Japan-Reference-Cited by-同舟云学术

Infliximab for very early‐onset inflammatory bowel disease: A tertiary center experience in Japan

Published:2019-11-14 Issue:4 Volume:35 Page:593-600
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Takeuchi Ichiro¹,Kaburaki Yoichiro¹²,Arai Katsuhiro¹^ORCID,Shimizu Hirotaka¹³,Hirano Yuri¹,Nagata Satoru²,Shimizu Toshiaki³

Affiliation:

1. Center for Pediatric Inflammatory Bowel Disease Division of GastroenterologyNational Center for Child Health and Development Tokyo Japan

2. Department of PediatricsTokyo Women's Medical University Tokyo Japan

3. Department of Pediatrics and Adolescent MedicineJuntendo University Graduate School of Medicine Tokyo Japan

Funder

Ministry of Health, Labour and Welfare

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.14836

Reference28 articles.

1. Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends

2. Incidence and phenotype at diagnosis of very early‐onset compared with later‐onset paediatric inflammatory bowel disease: a population‐based study [1988–2011];Bequet E;J. Crohns Colitis,2017

3. Temporal Trend of Pediatric Inflammatory Bowel Disease: Analysis of National Registry Data 2004 to 2013 in Japan

4. Clinical Presentation and Five-Year Therapeutic Management of Very Early-Onset Inflammatory Bowel Disease in a Large North American Cohort

5. The Age of Gene Discovery in Very Early Onset Inflammatory Bowel Disease

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging strategy towards mucosal healing in inflammatory bowel disease: what the future holds?;Frontiers in Immunology;2023-12-14

2. Infantile-onset inflammatory bowel disease has variable long-term outcomes;Frontiers in Pediatrics;2023-03-01

3. The treatment of inflammatory bowel disease with monoclonal antibodies in Asia;Biomedicine & Pharmacotherapy;2023-01

4. Canakinumab for the treatment of autoinflammatory very early onset- inflammatory bowel disease;Frontiers in Immunology;2022-09-20

5. New Insights and Advances in Pathogenesis and Treatment of Very Early Onset Inflammatory Bowel Disease;Frontiers in Pediatrics;2022-03-01